MBX Biosciences
Advancing potential breakthrough medicines for endocrine diseases of substantial medical need.
Launch date
Employees
Market cap
-
Enterprise valuation
€523m (Public information from Aug 2024)
Carmel Indiana (HQ)
Authorizing premium user...